维普中文期刊产品整合服务
9篇 您的检索式:作者名="Lebok"
    题名 作者 年代 出处 被引量
1Reduced anoctamin 7(ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer显示文摘Objective:Anoctamin 7(ANO7)is a calcium2+-dependent chloride ion channel protein.Its expression is restricted to prostate epithelial cells.The exact function is unknown.This study aimed to analyze ANO7 expression and its clinical significance in prostate cancer(PCa).Methods:ANO7 expression was assessed by immunohistochemistry in 17,747 clinical PCa specimens.Results:ANO7 was strongly expressed in normal prostate glandular cells but often less abundant in cancer cells.ANO7 staining was interpretable in 13,594 cancer tissues and considered strong in 34.4%,moderate in 48.7%,weak in 9.3%,and negative in 7.6%.Reduced staining was tightly linked to adverse tumor features[high classical and quantitative Gleason grade,lymph node metastasis,advanced tumor stage,high Ki67 labeling index,positive surgical margin,and early biochemical recurrence(P<0.0001 each)].The univariate Cox hazard ratio for prostate-specific antigen(PSA)recurrence after prostatectomy in patients with negative vs.strong ANO7 expression was 2.98(95%confidence interval 2.61–3.38).The prognostic impact was independent of established pre-or postoperatively available parameters(P<0.0001).Analysis of annotated molecular data showed that low ANO7 expression was linked to TMPRSS2:ERG fusions(P<0.0001),elevated androgen receptor expression(P<0.0001),as well as presence of 9 of 11 chromosomal deletions(P<0.05 each).A particularly strong association of low ANO7 expression with phosphatase and tensin homolog(PTEN)deletion may indicate a functional relationship with the PTEN/AKT pathway.Conclusions:These data identify reduced ANO7 protein expression as a strong and independent predictor of poor prognosis in PCa.ANO7 measurement,either alone or in combination,might provide clinically useful prognostic information in PCa.Andreas Marx Lena Koopmann Doris Hoflmayer Franziska Büscheck Claudia Hube-Magg Stefan Steurer Till Eichenauer Till S.Clauditz Waldemar Wilczak Ronald Simon Guido Sauter Jakob R.Izbicki Hartwig Huland Hans Heinzer Markus Graefen Alexander Haese Thorsten Schlomm Christian Bernreuther Patrick Lebok Sarah Bonk 2021Cancer Biology & Medicine2021,18,1:3
2Thermal Endurance Data for Solid Insulating Materials显示文摘Lebok F J 1982IEEE Transactions on Electrical Insulation1982,17,1:1
3Epidermal growth factor receptor (EGFR) in salivary gland carcinomas:potentials as therapeutic target显示文摘CLAUDITZ T S GONTAREWICZ A LEBOK P 2012Oral Oncol2012,48,10:1
4Epidermal growth factorreceptor (EGFR) in salivary gland carcinomas : potentials as thera-peutic target 显示文摘Clauditz TS Gontaewicz A Lebok P 2012Oral Oncol2012,12,:1
5Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC)显示文摘Clauditz TS yon Rheinbaben K Lebok P 2014Pathol Res Pract2014,210,64:1
6Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC)显示文摘Till Sebastian Clauditz Kirsten von Rheinbaben Patrick Lebok Sarah Minner Michael Tachezy Kerstin Borgmann Rainald Knecht Guido Sauter Waldemar Wilczak Marco Blessmann Adrian Münscher 2014Pathology - Research and Practice2014,,10:1
7A survey of nosocomial infections and their influ ence on hospital显示文摘Dinkel RH Lebok U 1994J-Hosp-Infect1994,28,4:1
8Partial PTEN de- letion is linked to poor prognosis in breast cancer 显示文摘Lebok P Kopperschmidt V Kluth M 2015BMC cancer2015,15,1:1
9Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: Potentials as therapeutic target显示文摘Till Sebastian Clauditz Artur Gontarewicz Patrick Lebok Maria-Christina Tsourlakis Tobias J. Grob Adrian Münscher Guido Sauter Carsten Bokemeyer Rainald Knecht Waldemar Wilczak 2012Oral Oncology2012,,10:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费